Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.78 |
| ▸ | XDH | P47989 | 2/20 | 0.57 |
| ▸ | JUN | P05412 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Picroside Ii SCHEMBL24209283 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL30387354 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL29425971 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL24209282 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Picroside Ii SCHEMBL29426003 | 1.00 | HSP90AA1 (0.78) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Verproside SCHEMBL31619362 | 0.92 | HSP90AA1 (0.83) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Verproside SCHEMBL2449966 | 0.92 | HSP90AA1 (0.83) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| SCHEMBL29425954 | 0.89 | HSP90AA1 (0.60) | HSP90AA1XDHJUNPOLBCTDSP1 | |
| Catalposide SCHEMBL419598 | 0.88 | HSP90AA1 (1.00) | HSP90AA1XDHPOLBCTDSP1KDM4E | |
| SCHEMBL29642990 | 0.86 | HSP90AA1 (0.85) | HSP90AA1XDHKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119757571-A | Universal inflammation recovery preparation characteristic spectrum and construction method and application thereof | 广西万通制药有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-117789993-B | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-06-11 | — | — | CN | claimed |
| CN-117582450-B | Pharmaceutical composition and preparation for preventing and treating arteriosclerosis, coronary heart disease and gout | 华医华药(山东)生物医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-112739423-B | Mineral sunscreen compositions with improved efficacy | 莱雅公司 | 2024-04-30 | — | — | CN | claimed |
| CN-114381484-B | Application of UGT85A1 or RrUGT3 in catalyzing various substrates to generate glycoside compounds | 山东大学 | 2024-04-19 | — | — | CN | claimed |
| CN-117582450-A | Pharmaceutical composition and preparation for preventing and treating arteriosclerosis, coronary heart disease and gout | 华医华药(山东)生物医药科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117343112-A | Preparation method of picrorhiza rhizome multi-component compound | 山东新时代药业有限公司 | 2024-01-05 | — | — | CN | claimed |
| US-11773098-B2 | Solid forms of a toll-like receptor modulator | GILEAD SCIENCES, INC. (US) | 2023-10-03 | — | — | US | claimed |
| CN-116510023-A | Application of chemical in preparation of product for preventing and/or treating chronic wound | 上海交通大学医学院附属第九人民医院 | 2023-08-01 | — | — | CN | claimed |
| CN-116399977-A | Method for simultaneously determining multiple components in liver-strengthening capsules based on liquid chromatography-mass spectrometry technology and application | 石家庄东方药业股份有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-113975398-B | Drug delivery carrier composition for treating liver fibrosis and preparation method thereof | 中国药科大学 | 2023-07-04 | — | — | CN | claimed |
| CN-116350681-A | Herba Ixeritis Denticulatae extract, and its preparation method and application | 珠海市藤栢医药有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-116264823-A | Modulation of non-coding RNAs, lymphocytes, neutrophils, inflammatory minibodies and p53 genes | 穆尼塞克哈尔·梅达萨尼 | 2023-06-16 | — | — | CN | claimed |
| CN-116102601-A | Separation preparation method of picroside II | 山东新时代药业有限公司 | 2023-05-12 | — | — | CN | claimed |
| WO-2023011512-A1 | CRYSTAL FORMS OF KUDING SAPONIN A COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 上海凯屹医药科技有限公司 | 2023-02-09 | — | — | WO | claimed |
| CN-114854680-A | Application of effective components in Manlongye to resisting aging of human umbilical cord mesenchymal stem cells | 云南云龙制药股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114717247-A | Cassava transcription factors MebHLH72 and MebHLH114 and application thereof in inhibition of synthesis of linarin | 中国热带农业科学院热带作物品种资源研究所 | 2022-07-08 | — | — | CN | claimed |
| WO-2022135331-A1 | STABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING KUDING SAPONIN COMPOUND | 上海凯屹医药科技有限公司 | 2022-06-30 | — | — | WO | claimed |
| CN-114166956-A | Method for rapidly detecting phlorizin and trilobatin in leaves of lithocarpus polystachyus rehd | 广西壮族自治区林业科学研究院 | 2022-03-11 | — | — | CN | claimed |
| CN-114106067-A | Process for extracting picroside from rhizoma picrorhizae by fermentation | 山东康裕生物科技有限公司 | 2022-03-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773098-B2 | Solid forms of a toll-like receptor modulator | TLR4, TLR3, TLR6 | HSP90AA1 581/4885XDH 2180/4885JUN 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.